Global Hemophilia Treatment Drugs Industry Market Analysis & Forecast 2018-2023 Chapter 1 Hemophilia Treatment Drugs Market Overview 1.1 Product Overview and Scope of Hemophilia Treatment Drugs 1.2 Hemophilia Treatment Drugs Market Segmentation by Type in 2016 1.2.1 Global Production Market Share of Hemophilia Treatment Drugs by Type in 2016 1.2.1 Recombinant Coagulation Factor Concentrates 1.2.2 Plasma Derived Coagulation Factor 1.2.3 Others 1.3 Hemophilia Treatment Drugs Market Segmentation by Application in 2016 1.3.1 Hemophilia Treatment Drugs Consumption Market Share by Application in 2016 1.3.2 Hemophilia A 1.3.3 Hemophilia B 1.3.4 Others 1.4 Hemophilia Treatment Drugs Market Segmentation by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 1.5 Global Market Size (Value) of Hemophilia Treatment Drugs (2013-2023) 1.5.1 Global Product Sales and Growth Rate (2013-2023) 1.5.2 Global Product Revenue and Growth Rate (2013-2023) Chapter 2 Global Economic Impact on Hemophilia Treatment Drugs Industry 2.1 Global Macroeconomic Environment Analysis 2.1.1 Global Macroeconomic Analysis 2.1.2 Global Macroeconomic Environment Development Trend 2.2 Global Macroeconomic Environment Analysis by Regions Chapter 3 Global Hemophilia Treatment Drugs Market Competition by Manufacturers 3.1 Global Hemophilia Treatment Drugs Production and Share by Manufacturers (2016 and 2017) 3.2 Global Hemophilia Treatment Drugs Revenue and Share by Manufacturers (2016 and 2017) 3.3 Global Hemophilia Treatment Drugs Average Price by Manufacturers (2016 and 2017) 3.4 Manufacturers Hemophilia Treatment Drugs Manufacturing Base Distribution, Production Area and Product Type 3.5 Hemophilia Treatment Drugs Market Competitive Situation and Trends 3.5.1 Hemophilia Treatment Drugs Market Concentration Rate 3.5.2 Hemophilia Treatment Drugs Market Share of Top 3 and Top 5 Manufacturers 3.5.3 Mergers & Acquisitions, Expansion Chapter 4 Global Hemophilia Treatment Drugs Production, Revenue (Value) by Region (2013-2018) 4.1 Global Hemophilia Treatment Drugs Production by Region (2013-2018) 4.2 Global Hemophilia Treatment Drugs Production Market Share by Region (2013-2018) 4.3 Global Hemophilia Treatment Drugs Revenue (Value) and Market Share by Region (2013-2018) 4.4 Global Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.5 North America Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.5.1 North AmericaHemophilia Treatment DrugsProduction and Market Share by Manufacturers 4.5.2 North AmericaHemophilia Treatment DrugsProduction and Market Share by Type 4.5.3 North AmericaHemophilia Treatment DrugsProduction and Market Share by Application 4.6 Europe Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.6.1 EuropeHemophilia Treatment DrugsProduction and Market Share by Manufacturers 4.6.2 Europe Hemophilia Treatment Drugs Production and Market Share by Type 4.6.3 Europe Hemophilia Treatment Drugs Production and Market Share by Application 4.7 China Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.7.1 ChinaHemophilia Treatment DrugsProduction and Market Share by Manufacturers 4.7.2 China Hemophilia Treatment Drugs Production and Market Share by Type 4.7.3 China Hemophilia Treatment Drugs Production and Market Share by Application 4.8 Japan Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.8.1 Japan Hemophilia Treatment Drugs Production and Market Share by Manufacturers 4.8.2 Japan Hemophilia Treatment Drugs Production and Market Share by Type 4.8.3 Japan Hemophilia Treatment Drugs Production and Market Share by Application 4.9 Southeast Asia Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.9.1 Southeast Asia Hemophilia Treatment Drugs Production and Market Share by Manufacturers 4.9.2 Southeast Asia Hemophilia Treatment Drugs Production and Market Share by Type 4.9.3 Southeast Asia Hemophilia Treatment Drugs Production and Market Share by Application 4.10 India Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) 4.10.1 India Hemophilia Treatment Drugs Production and Market Share by Manufacturers 4.10.2 India Hemophilia Treatment Drugs Production and Market Share by Type 4.10.3 India Hemophilia Treatment Drugs Production and Market Share by Application Chapter 5 Global Hemophilia Treatment Drugs Supply (Production), Consumption, Export, Import by Regions (2013-2018) 5.1 Global Hemophilia Treatment Drugs Consumption by Regions (2013-2018) 5.2 North America Hemophilia Treatment Drugs Production, Consumption, Export, Import by Regions (2013-2018) 5.3 Europe Hemophilia Treatment Drugs Production, Consumption, Export, Import by Regions (2013-2018) 5.4 China Hemophilia Treatment Drugs Production, Consumption, Export, Import by Regions (2013-2018) 5.5 Japan Hemophilia Treatment Drugs Production, Consumption, Export, Import by Regions (2013-2018) 5.6 Southeast Asia Hemophilia Treatment Drugs Production, Consumption, Export, Import by Regions (2013-2018) 5.7 India Hemophilia Treatment Drugs Production, Consumption, Export, Import by Regions (2013-2018) Chapter 6 Global Hemophilia Treatment Drugs Production, Revenue (Value), Price Trend by Type 6.1 Global Hemophilia Treatment Drugs Production and Market Share by Type (2013-2018) 6.2 Global Hemophilia Treatment Drugs Revenue and Market Share by Type (2013-2018) 6.3 Global Hemophilia Treatment Drugs Price by Type (2013-2018) 6.4 Global Hemophilia Treatment Drugs Production Growth by Type (2013-2018) Chapter 7 Global Hemophilia Treatment Drugs Market Analysis by Application 7.1 Global Hemophilia Treatment Drugs Consumption and Market Share by Application (2013-2018) 7.2 Global Hemophilia Treatment Drugs Revenue and Market Share by Type (2013-2018) 7.3 Global Hemophilia Treatment Drugs Consumption Growth Rate by Application (2013-2018) 7.4 Market Drivers and Opportunities 7.4.1 Potential Applications 7.4.2 Emerging Markets/Countries Chapter 8 Global Hemophilia Treatment Drugs Manufacturers Analysis 8.1 Pfizer 8.1.1 Company Basic Information, Manufacturing Base and Competitors 8.1.2 Product Type, Application and Specification 8.1.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.1.4 Business Overview 8.2 Biotest 8.2.1 Company Basic Information, Manufacturing Base and Competitors 8.2.2 Product Type, Application and Specification 8.2.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.2.4 Business Overview 8.3 CSL Behring 8.3.1 Company Basic Information, Manufacturing Base and Competitors 8.3.2 Product Type, Application and Specification 8.3.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.3.4 Business Overview 8.4 Kedrion 8.4.1 Company Basic Information, Manufacturing Base and Competitors 8.4.2 Product Type, Application and Specification 8.4.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.4.4 Business Overview 8.5 Octapharma 8.5.1 Company Basic Information, Manufacturing Base and Competitors 8.5.2 Product Type, Application and Specification 8.5.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.5.4 Business Overview 8.6 Shire 8.6.1 Company Basic Information, Manufacturing Base and Competitors 8.6.2 Product Type, Application and Specification 8.6.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.6.4 Business Overview 8.7 Novo Nordisk 8.7.1 Company Basic Information, Manufacturing Base and Competitors 8.7.2 Product Type, Application and Specification 8.7.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.7.4 Business Overview 8.8 Bayer 8.8.1 Company Basic Information, Manufacturing Base and Competitors 8.8.2 Product Type, Application and Specification 8.8.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.8.4 Business Overview 8.9 F. Hoffmann-La Roche 8.9.1 Company Basic Information, Manufacturing Base and Competitors 8.9.2 Product Type, Application and Specification 8.9.3 Production, Revenue, Price and Gross Margin (2013-2018) 8.9.4 Business Overview … Chapter 9 Hemophilia Treatment Drugs Manufacturing Cost Analysis 9.1 Hemophilia Treatment Drugs Key Raw Materials Analysis 9.1.1 Key Raw Materials 9.1.2 Price Trend of Key Raw Materials 9.1.3 Key Suppliers of Raw Materials 9.1.4 Market Concentration Rate of Raw Materials 9.2 Proportion of Manufacturing Cost Structure 9.2.1 Raw Materials 9.2.2 Labor Cost 9.2.3 Manufacturing Expenses 9.3 Manufacturing Process Analysis of Hemophilia Treatment Drugs Chapter 10 Industrial Chain, Sourcing Strategy and Downstream Buyers 10.1 Hemophilia Treatment Drugs Industrial Chain Analysis 10.2 Upstream Raw Materials Sourcing 10.3 Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2016 10.4 Downstream Buyers Chapter 11 Marketing Strategy Analysis, Distributors/Traders 11.1 Marketing Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Development Trend 11.2 Market Positioning 11.2.1 Pricing Strategy 11.2.2 Brand Strategy 11.2.3 Target Client 11.3 Distributors/Traders List Chapter 12 Market Effect Factors Analysis 12.1 Technology Progress/Risk 12.1.1 Substitutes Threat 12.1.2 Technology Progress in Related Industry 12.2 Consumer Needs/Customer Preference Change 12.3 Economic/Political Environmental Change Chapter 13 Global Hemophilia Treatment Drugs Market Forecast (2018-2023) 13.1 Global Hemophilia Treatment Drugs Production, Revenue Forecast (2018-2023) 13.2 Global Hemophilia Treatment Drugs Production, Consumption Forecast by Regions (2018-2023) 13.3 Global Hemophilia Treatment Drugs Production Forecast by Type (2018-2023) 13.4 Global Hemophilia Treatment Drugs Consumption Forecast by Application (2018-2023) 13.5 Hemophilia Treatment Drugs Price Forecast (2018-2023) Chapter 14 Appendix

Figure Picture of Hemophilia Treatment Drugs Figure Global Production Market Share of Hemophilia Treatment Drugs by Plasma Derived Coagulation Factor016 Figure Product Picture of Type I Table Major Manufacturers of Type I Figure Product Picture of Type II Table Major Manufacturers of Type II Figure Product Picture of Type III Table Major Manufacturers of Type III Table Hemophilia Treatment Drugs Consumption Market Share by Application in 2016 Figure Hemophilia A Examples Figure Hemophilia B Examples Figure Others Examples Figure North America Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Europe Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure China Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Japan Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Southeast Asia Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure India Hemophilia Treatment Drugs Revenue (Million USD) and Growth Rate (2013-2023) Figure Global Hemophilia Treatment Drugs Revenue (Million UDS) and Growth Rate (2013-2023) Table Global Hemophilia Treatment Drugs Capacity of Key Manufacturers (2016 and 2017) Table Global Hemophilia Treatment Drugs Capacity Market Share by Manufacturers (2016 and 2017) Figure Global Hemophilia Treatment Drugs Capacity of Key Manufacturers in 2016 Figure Global Hemophilia Treatment Drugs Capacity of Key Manufacturers in 2017 Table Global Hemophilia Treatment Drugs Production of Key Manufacturers (2016 and 2017) Table Global Hemophilia Treatment Drugs Production Share by Manufacturers (2016 and 2017) Figure 2015 Hemophilia Treatment Drugs Production Share by Manufacturers Figure 2016 Hemophilia Treatment Drugs Production Share by Manufacturers Table Global Hemophilia Treatment Drugs Revenue (Million USD) by Manufacturers (2016 and 2017) Table Global Hemophilia Treatment Drugs Revenue Share by Manufacturers (2016 and 2017) Table 2015 Global Hemophilia Treatment Drugs Revenue Share by Manufacturers Table 2016 Global Hemophilia Treatment Drugs Revenue Share by Manufacturers Table Global Market Hemophilia Treatment Drugs Average Price of Key Manufacturers (2016 and 2017) Figure Global Market Hemophilia Treatment Drugs Average Price of Key Manufacturers in 2016 Table Manufacturers Hemophilia Treatment Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers Hemophilia Treatment Drugs Product Type Figure Hemophilia Treatment Drugs Market Share of Top 3 Manufacturers Figure Hemophilia Treatment Drugs Market Share of Top 5 Manufacturers Table Global Hemophilia Treatment Drugs Capacity by Regions (2013-2018) Figure Global Hemophilia Treatment Drugs Capacity Market Share by Regions (2013-2018) Figure Global Hemophilia Treatment Drugs Capacity Market Share by Regions (2013-2018) Figure 2015 Global Hemophilia Treatment Drugs Capacity Market Share by Regions Table Global Hemophilia Treatment Drugs Production by Regions (2013-2018) Figure Global Hemophilia Treatment Drugs Production and Market Share by Regions (2013-2018) Figure Global Hemophilia Treatment Drugs Production Market Share by Regions (2013-2018) Figure 2015 Global Hemophilia Treatment Drugs Production Market Share by Regions Table Global Hemophilia Treatment Drugs Revenue by Regions (2013-2018) Table Global Hemophilia Treatment Drugs Revenue Market Share by Regions (2013-2018) Table 2015 Global Hemophilia Treatment Drugs Revenue Market Share by Regions Table Global Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table North America Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Europe Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table China Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Japan Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Southeast Asia Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table India Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Global Hemophilia Treatment Drugs Consumption Market by Regions (2013-2018) Table Global Hemophilia Treatment Drugs Consumption Market Share by Regions (2013-2018) Figure Global Hemophilia Treatment Drugs Consumption Market Share by Regions (2013-2018) Figure 2015 Global Hemophilia Treatment Drugs Consumption Market Share by Regions Table North America Hemophilia Treatment Drugs Production, Consumption, Import & Export (2013-2018) Table Europe Hemophilia Treatment Drugs Production, Consumption, Import & Export (2013-2018) Table China Hemophilia Treatment Drugs Production, Consumption, Import & Export (2013-2018) Table Japan Hemophilia Treatment Drugs Production, Consumption, Import & Export (2013-2018) Table Southeast Asia Hemophilia Treatment Drugs Production, Consumption, Import & Export (2013-2018) Table India Hemophilia Treatment Drugs Production, Consumption, Import & Export (2013-2018) Table Global Hemophilia Treatment Drugs Production by Type (2013-2018) Table Global Hemophilia Treatment Drugs Production Share by Type (2013-2018) Figure Production Market Share of Hemophilia Treatment Drugs by Type (2013-2018) Figure 2015 Production Market Share of Hemophilia Treatment Drugs by Type Table Global Hemophilia Treatment Drugs Revenue by Type (2013-2018) Table Global Hemophilia Treatment Drugs Revenue Share by Type (2013-2018) Figure Production Revenue Share of Hemophilia Treatment Drugs by Type (2013-2018) Figure 2015 Revenue Market Share of Hemophilia Treatment Drugs by Type Table Global Hemophilia Treatment Drugs Price by Type (2013-2018) Figure Global Hemophilia Treatment Drugs Production Growth by Type (2013-2018) Table Global Hemophilia Treatment Drugs Consumption by Application (2013-2018) Table Global Hemophilia Treatment Drugs Consumption Market Share by Application (2013-2018) Figure Global Hemophilia Treatment Drugs Consumption Market Share by Application in 2016 Table Global Hemophilia Treatment Drugs Consumption Growth Rate by Application (2013-2018) Figure Global Hemophilia Treatment Drugs Consumption Growth Rate by Application (2013-2018) Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors Table Pfizer Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Pfizer Hemophilia Treatment Drugs Market Share (2013-2018) Table Biotest Basic Information, Manufacturing Base, Production Area and Its Competitors Table Biotest Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Biotest Hemophilia Treatment Drugs Market Share (2013-2018) Table CSL Behring Basic Information, Manufacturing Base, Production Area and Its Competitors Table CSL Behring Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table CSL Behring Hemophilia Treatment Drugs Market Share (2013-2018) Table Kedrion Basic Information, Manufacturing Base, Production Area and Its Competitors Table Kedrion Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Kedrion Hemophilia Treatment Drugs Market Share (2013-2018) Table Octapharma Basic Information, Manufacturing Base, Production Area and Its Competitors Table Octapharma Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Octapharma Hemophilia Treatment Drugs Market Share (2013-2018) Table Shire Basic Information, Manufacturing Base, Production Area and Its Competitors Table Shire Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Shire Hemophilia Treatment Drugs Market Share (2013-2018) Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors Table Novo Nordisk Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Novo Nordisk Hemophilia Treatment Drugs Market Share (2013-2018) Table Bayer Basic Information, Manufacturing Base, Production Area and Its Competitors Table Bayer Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table Bayer Hemophilia Treatment Drugs Market Share (2013-2018) Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Production Area and Its Competitors Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Production, Revenue, Price and Gross Margin (2013-2018) Table F. Hoffmann-La Roche Hemophilia Treatment Drugs Market Share (2013-2018) … Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Hemophilia Treatment Drugs Figure Manufacturing Process Analysis of Hemophilia Treatment Drugs Figure Hemophilia Treatment Drugs Industrial Chain Analysis Table Raw Materials Sources of Hemophilia Treatment Drugs Major Manufacturers in 2016 Table Major Buyers of Hemophilia Treatment Drugs Table Distributors/Traders List Figure Global Hemophilia Treatment Drugs Production and Growth Rate Forecast (2018-2023) Figure Global Hemophilia Treatment Drugs Revenue and Growth Rate Forecast (2018-2023) Table Global Hemophilia Treatment Drugs Production Forecast by Regions (2018-2023) Table Global Hemophilia Treatment Drugs Consumption Forecast by Regions (2018-2023) Table Global Hemophilia Treatment Drugs Production Forecast by Type (2018-2023) Table Global Hemophilia Treatment Drugs Consumption Forecast by Application (2018-2023)

Pfizer Biotest CSL Behring Kedrion Octapharma Shire Novo Nordisk Bayer F. Hoffmann-La Roche